FOXD3 and neoplasm: In summary, for the first time, we have demonstrated that FOXD3 is down-regulated in human NB, and FOXD3 exhibits tumor suppressor activity that affects the growth, invasion, metastasis, and angiogenesis of NB cells in vitro and in vivo through direct transcriptional regulation of NDRG1.